We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Oxford Instruments and GE Announce Licensing Deal

By HospiMedica staff writers
Posted on 03 Jun 2004
Print article
Oxford Instruments Superconductivity (OIS; Abingdon, UK) recently announced an agreement whereby GE Healthcare (Waukesha, WI, USA) will exclusively license in vitro rights to its proprietary dynamic nuclear polarization (DNP) technology for the creation of the world's first DNP nuclear magnetic resonance (NMR) instrument.

Traditional NMR, although a data-rich method, has always been limited by a lack of sensitivity, causing scientists to look for alternative, and often complicated and expensive ways of tackling this hurdle.



Related Links:
Oxford Instruments Superconductivity
GE Healthcare
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Medical Magnifier
EX-06
New
Fixed Volume Dispense Pump
LPL Series

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.